Fluocinolone Acetonide Implant for Uveitis: Dissecting Responder and Non-Responder Outcomes at a Tertiary Center.

ILUVIEN OZURDEX dexamethasone fluocinolone intravitreal implant intraocular inflammation macular edema non-infectious uveitis pars plana vitrectomy (PPV) sustained release corticosteroid visual acuity

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
16 May 2024
Historique:
received: 04 04 2024
revised: 08 05 2024
accepted: 10 05 2024
medline: 25 5 2024
pubmed: 25 5 2024
entrez: 25 5 2024
Statut: epublish

Résumé

Macular edema (ME) remains a primary cause of visual deterioration in uveitis. Visual acuity (VA) can often be maintained using corticosteroid depot systems. This study evaluated the efficacy of a fluocinolone acetonide (FAc) intravitreal implant (ILUVIEN

Identifiants

pubmed: 38791073
pii: biomedicines12051106
doi: 10.3390/biomedicines12051106
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Jasmin Abu Arif (J)

Department of Ophthalmology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, 10117 Berlin, Germany.

Vitus André Knecht (VA)

Department of Ophthalmology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, 10117 Berlin, Germany.

Anne Rübsam (A)

Department of Ophthalmology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, 10117 Berlin, Germany.
Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Charité Platz 1, 10117 Berlin, Germany.

Vanessa Lussac (V)

Department of Ophthalmology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, 10117 Berlin, Germany.

Zohreh Jami (Z)

Department of Ophthalmology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, 10117 Berlin, Germany.

Dominika Pohlmann (D)

Department of Ophthalmology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, 10117 Berlin, Germany.
Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Charité Platz 1, 10117 Berlin, Germany.

Bert Müller (B)

Department of Ophthalmology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, 10117 Berlin, Germany.

Uwe Pleyer (U)

Department of Ophthalmology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, 10117 Berlin, Germany.
Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Charité Platz 1, 10117 Berlin, Germany.

Classifications MeSH